Soluble CD146 as a biomarker of acutely decompensated HF New-onset HF risk after hospitalisation for pneumonia in the elderly Gender and outcomes after primary prevention ICD Impaired systolic function in HFPEF and the impact of spironolactone Changes in LVEF and outcomes in primary prevention ICD and CRT recipients Typical LBBB contraction adds to ECG for predicting outcomes after CRT Prognostic role of chloride levels in acute decompensated HF Thromboembolic risk stratification of patients hospitalised with HF in sinus rhythm 2D-SE = two-dimensional strain echocardiography; AF = atrial fibrillation; CRT = cardiac resynchronisation therapy; CSA = central sleep apnoea; CV = cardiovascular; ECG = electrocardiography; EF = ejection fraction; HF = heart failure; HF(P/R)EF = HF (with preserved/reduced) EF; HR = hazard ratio; ICD = implantable cardioverter defibrillator; LBBB = left bundle branch block; LV = left ventricular; NT-proBNP = N-terminal prohormone of brain natriuretic peptide. , but severe in-hospital complications, including shock and death, did not differ significantly (p=0.93). Independent predictors of in-hospital complications were physical triggers, acute neurological or psychiatric diseases, high troponin levels and low EF on admission. The respective major adverse cardiac/cerebrovascular event and mortality rates were 9.9% and 5.6% per patient-year over long-term follow-up.
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Comment: The 9:1 female predominance for takotsubo cardiomyopathy is well established, with 79% of patients in this study women aged over 50 years. Whilst emotional triggers were identified in approximately one-quarter of cases, over one-third were preceded by a physical trigger. Although often considered relatively benign, the in-hospital rate of major adverse events was similar to that seen in patients with acute coronary syndromes, and the subsequent mortality rate was 5.6% per annum. The rate of recurrence was 1.8% per annum, spanning between 25 days and 9 years. The high prevalence of neurological and psychiatric disorders is interesting, and suggests that these factors should be considered in the secondary prevention of further episodes.
Reference: N Engl J Med 2015; 373(10) :929-38 Abstract Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure Authors: Gayat E et al. Summary: These researchers measured NT-proBNP and soluble CD146 levels in 391 patients presenting to an emergency department with acute dyspnoea. Areas under the receiver operating characteristic curves for acute decompensated HF diagnosis were 0.86 and 0.90 for soluble CD146 and NT-proBNP, respectively. Adding soluble CD146 to NT-proBNP levels improved the diagnostic performance for patients lying in the NT-proBNP grey zone (p=0.02) and had potential for ruling-out acute decompensated HF. An experimental rat model of acute decompensated HF suggested that CD146 expression occurs in the intima of large arteries and is associated with both LV function and organ congestion.
Comment: This multicentre study involving four European countries demonstrated that soluble CD146 (which has up to now been considered a marker of endothelial dysfunction) had similar diagnostic accuracy to NT-proBNP in distinguishing cardiac and noncardiac dyspnoea in the emergency department setting. Furthermore, it appeared to be particularly useful in reclassifying patients with a 'grey-zone' NT-proBNP. These findings will need to be independently validated, and future studies will need to evaluate its incremental utility compared with other putative HF biomarkers.
Reference: Int J Cardiol 2015; 15(199):241-7 Abstract Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults Comment: Although pneumonia has previously been identified as a trigger for HF, this analysis suggests a longer term risk of incident HF, similar to that seen with established HF risk factors. Whilst it is difficult to completely exclude the possibility of pre-existing subclinical HF or shared risk factors, the authors undertook a number of analyses that suggest there may be a mechanistic link. Either way, these findings suggest that a diagnosis of pneumonia may provide an opportunity to screen for HF or structural heart disease. Furthermore, they emphasise the importance of considering broader approaches to disease management in chronic disease.
Reference: Am Heart J 2015; 170(2) Comment: Women have been under-represented in the randomised controlled trials evaluating the efficacy of ICD therapy; however, a recent meta-analysis reported no significant difference in the mortality relative odds ratios between men and women. The current study compared older men and women who received a primary prevention ICD in real-world practice, with a focus on postdischarge outcomes. Whilst the higher complication rate in women may be anticipated based upon differences in body size and underlying disease severity, these differences persisted in adjusted analyses and were accompanied by higher HF and all-cause hospitalisation rates and a trend to higher mortality. Whilst the possibility of unmeasured residual confounders such as frailty and comorbidity severity remains, future studies will need to determine whether these findings apply in other healthcare systems.
Reference: Am Heart J 2015;170(2):330-8 Abstract
Prognostic importance of impaired systolic function in heart failure with preserved ejection fraction and the impact of spironolactone Authors: Shah AM et al. Summary: Using two-dimensional speckle-tracking echocardiography, these researchers ascertained that 52% of 447 participants with HFPEF from the TOPCAT trial had impaired LV longitudinal strain. During median follow-up of 2.6 years, 115 participants experienced a primary composite outcome event (CV death, HF hospitalisation or aborted cardiac arrest), and the risk was increased in the participants with impaired LV longitudinal strain (adjusted HR 2.14 [95% CI 1.26-3.66]), as were the individual risks of CV death (3.20 [1.44-7.12]) and HF hospitalisation (2.23 [1.16-4.28]). Furthermore, among echocardiographic predictors of the composite outcome, LV longitudinal strain was the strongest. An exploratory analysis of 131 participants with LV longitudinal strain assessed after 12-18 months showed that spironolactone was associated with a trend toward LV longitudinal strain improvement, but only in participants enrolled in the Americas, not in Russia or Georgia.
Comment: Previous studies using myocardial deformation indices have identified abnormal systolic function in some patients with HFPEF. This subgroup analysis from the TOPCAT study identified that 52% of their HFPEF patients had reduced absolute mean longitudinal strain (<15.8%), although >90% of these patients had associated LV hypertrophy and/or increased E/E'. Abnormal longitudinal strain was an adverse prognostic marker, even when the analysis was restricted to patients with an LVEF >55%. Our current definition of HFPEF captures a broad range of cardiac and noncardiac conditions with differing mechanisms contributing to their clinical phenotype. Ideally, future HFPEF studies should include measures of myocardial deformation to determine whether this could be used to guide treatment selection and monitor response to therapy. † In patients with heart failure and left ventricular impairment within 3-14 days of acute myocardial infarction, in combination with standard therapy.
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Comment: These findings are consistent with other observational studies and a recent report from MADIT-CRT. As expected, improved LVEF was associated with better survival and a reduced rate of appropriate shocks, although appropriate shocks still occurred in four out of 134 patients whose LVEF had increased to >35%. Unfortunately, the event rate in patients with an LVEF >55% were not reported separately, although the final numbers would have been small. This study suggests that whilst the decision to replace an ICD generator (or downgrade to CRT alone) may be informed by the subsequent change in LVEF, other factors also contribute to the residual risk of sudden death events.
Reference: J Am Coll Cardiol 2015;66(5):524-31 Abstract
Identification of typical left bundle branch block contraction by strain echocardiography is additive to electrocardiography in prediction of long-term outcome after cardiac resynchronization therapy Authors: Risum N et al.
Summary:
The association between absence of a typical LBBB mechanical activation pattern by 2D-SE (two-dimensional strain echocardiography) and unfavourable long-term outcomes was explored in 208 candidates for CRT (New York Heart Association classes II-IV, EF ≤35%, QRS duration ≥120 msec) with LBBB on ECG; a typical LBBB contraction pattern was identified in 63% of the patients. A primary endpoint event (death, LV assist device or heart transplant over 4 years) was recorded for 23% of the patients. The risk of an adverse outcome was increased in patients with absence of typical LBBB contraction (adjusted HR 3.1 [95% Cl 1.64-5.88]). When pattern assessment was added to a risk prediction model that included QRS duration and ischaemic heart disease, its net reclassification index and C-statistics significantly improved. No association was seen between use of the strict LBBB ECG criteria and outcome ). LBBB contraction pattern assessment was significantly superior to time-to-peak indices of dyssynchrony (p<0.01 for all).
Comment: The PROSPECT and ECHO-CRT studies have decreased enthusiasm for using echocardiographic-dyssynchrony measures (using time-to-peak indices) to select patients for CRT. In this study, 2D-SE was performed in patients with LBBB on their 12-lead ECG who were undergoing CRT. Patients without a typical LBBB contraction pattern had worse outcomes. Whilst, it is tempting to speculate that these patients were 'CRT nonresponders', the absence of a control group does not allow this. It would be interesting to test whether 2D-SE could be used to select CRT in patients with an intermediate QRS duration (120-140 msec), especially given that only one-third of these patients had a typical LBBB contraction pattern. However, even if 2D-SE did identify CRT responders, broader application would require vendor-independent measures and be facilitated by an automated approach.
Reference: J Am Coll Cardiol 2015; 66(6):631-41 Abstract Prognostic role of serum chloride levels in acute decompensated heart failure Authors: Grodin JL et al. Summary: This research investigated the prognostic significance of serum chloride levels in relation to serum sodium levels in 1318 consecutive patients with chronic HF admitted for acute decompensated HF. An independent inverse association was seen between each unit change in serum chloride level on admission and long-term mortality (adjusted HR 0.93 [95% CI 0.90-0.97]), whereas sodium levels on admission were not significantly related after multivariate risk adjustment (p>0.05); a similar relationship was seen between each unit change in serum chloride level on admission and 1-year mortality in an independent validation cohort of 876 patients with acute decompensated 
]).
Comment: In this cohort of consecutive patients admitted with acute decompensated HF, serum chloride levels were inversely associated with markers of neurohormonal activation and mortality, with serum chloride levels <96 mEq/L being associated with higher mortality. Furthermore, serum chloride level appeared to be a stronger prognostic marker than serum sodium level, which was no longer predictive in a multivariable model that incorporated serum chloride level. These results were subsequently confirmed in a validation cohort. Future studies are required to confirm these findings and determine whether they apply in patients with either HFPEF or HFREF.
